2 withdrawn, 1 active not recruiting, 1 completed. 4 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Withdrawn 2, Active not recruiting 1, Completed 1 |
| Phase 2 | 3 | Withdrawn 2, Active not recruiting 1 |
Follow Uncomplicated Falciparum Malaria: new trials by email Literature Review of Uncomplicated Falciparum Malaria trials Research Report on Uncomplicated Falciparum Malaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials Artemether-lumefantrine, Dihydroartemisinin-piperaquine - Uncomplicated Falciparum Malaria | Phase 2 / Phase 3 | Active not recruiting | Johns Hopkins Bloomberg School of Public Health | 182 | 2019-06-19 | 2025-12-17 |
| Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar Arterolane maleate-piperaquine phosphate (Synriam), Dihydroartemisinin-piperaquine phosphate (Duocotexin) - Uncomplicated Falciparum Malaria, Artemisinin-resistant | Phase 2 / Phase 3 | Withdrawn | University of Oxford | 2015-06-01 | 2015-11-03 | |
| Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia Artemisone/Mefloquine (AmiM3), Artesunate - Uncomplicated Falciparum Malaria | Phase 2 / Phase 3 | Withdrawn | University of Oxford | 2010-10-01 | 2018-08-31 | |
| A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan Dihydroartemisinin + Piperaquine (Artekin), artesunate-sulphadoxin/pyrimethamine, chloroquine - Uncomplicated Falciparum Malaria, Vivax Malaria | Phase 3 | Completed | University of Oxford | 1086 | 2007-07-01 | 2018-05-09 |
Malaria, Falciparum (2) · Malaria, Vivax (1)
Infections (2) · Malaria (2) · Mosquito-Borne Diseases (2) · Parasitic Diseases (2) · Protozoan Infections (2) · Vector Borne Diseases (2)
Artemether, Lumefantrine Drug Combination (1) · Artesunate (1) · Chloroquine (1) · Mefloquine (1) · Pyrimethamine (1) · artemisone (1) · artenimol (1) · piperaquine (1)
University of Oxford (3) · Johns Hopkins Bloomberg School of Public Health (1)
Afghanistan (1) · Cambodia (1) · Zambia (1)
Arjen M Dondorp, MD (1) · Duong Socheat, MD (1) · Ghulam R Awab, MD (1) · William J Moss, MD MPH (1)